Isaac Zentner

Isaac Zentner is the Associate Director of the Vector Group in the Process Development Department at Carisma Therapeutics. He is currently helping Carisma Therapeutics advance their mission of revolutionizing cancer treatments through their first-in-class first-in-human CAR-Macrophage cell therapy. Isaac received his PhD in Molecular and Cell Biology and Genetics from Drexel University College of Medicine. He utilizes his experience in drug discovery and infectious disease to develop and optimize clinical manufacturing of viral vectors, such as AAV and Adenovirus. He believes in keeping the goal of ‘improving patient outcomes’ as the primary motivator in all aspects of his biomedical research